Product Information
SETLAKIN 0.15 MG-0.03 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.2267 per EA under NDC 16714036603. Its NADAC has been published 569 times since Nov 11, 2015.
FDA first approved this application on Sep 15, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
16714036603
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA090716FDA Approved
9/15/2014
TE Code
AB
On Market Since
8/1/2015
Price Statistics
The NADAC for SETLAKIN 0.15 MG-0.03 MG TAB has been published 569 times since Nov 11, 2015, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2267 per EA |
|---|---|
| All-time high | $0.9955 (Apr 13, 2016) |
| All-time low | $0.1058 (Nov 20, 2024) |
| 52-week high | $0.2267 |
| 52-week low | $0.1515 |
| Median price | $0.2562 |
| Average price | $0.3450 |
| Largest weekly change | +55.0% (Aug 21, 2024) |
| Weeks tracked | 569 |
| Tracking since | Nov 11, 2015 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SETLAKIN 0.15 MG-0.03 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for SETLAKIN 0.15 MG-0.03 MG TAB, manufactured by NorthStar Rx LLC, is $0.2267 per EA (NDC 16714036603), effective Sep 30, 2026.
How has the price of SETLAKIN 0.15 MG-0.03 MG TAB changed over time?
Over the history we have for it, the NADAC for SETLAKIN 0.15 MG-0.03 MG TAB has declined 75.7%. It has been tracked across 569 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for SETLAKIN 0.15 MG-0.03 MG TAB?
Since Nov 11, 2015, the NADAC for SETLAKIN 0.15 MG-0.03 MG TAB has ranged from a low of $0.1058 (Nov 20, 2024) to a high of $0.9955 (Apr 13, 2016), with a median of $0.2562 per EA.
Are there cheaper alternatives to SETLAKIN 0.15 MG-0.03 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1135 per EA — about 50% below SETLAKIN 0.15 MG-0.03 MG TAB.
Who manufactures SETLAKIN 0.15 MG-0.03 MG TAB?
SETLAKIN 0.15 MG-0.03 MG TAB (NDC 16714036603) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.